New Enterprise Associates, Inc. is a private equity and venture capital firm founded in 1977 and headquartered in Menlo Park, California, with additional offices in India and China. The firm specializes in investing across various stages of business development, from seed funding to public offerings, with a strong emphasis on the technology and healthcare sectors. Its investment strategy encompasses a wide range of industries, including information technology, consumer internet, financial technology, software, healthcare services, life sciences, biopharmaceuticals, and energy technology. New Enterprise Associates actively engages with entrepreneurs to support the growth of their companies, making investments between $0.05 million and $20 million. The firm has a global investment focus, particularly in regions such as Asia, Brazil, and the United States.
Vori Health is a healthcare provider focused on treating musculoskeletal conditions through an integrated care delivery model. Founded in 2020 and headquartered in New York, the organization offers a comprehensive range of services, including physical therapy, medical assessments, lab and imaging orders, health coaching, and nutritional guidance. Vori Health employs a virtual-first approach to connect patients with a collaborative care team, consisting of board-certified physical medicine physicians, health coach navigators, and physical therapists. This model aims to facilitate effective management of back, neck, and joint issues, guiding patients toward optimal wellness and recovery. By combining evidence-based practices with personalized support, Vori Health strives to improve patient outcomes in musculoskeletal care.
Abcuro
Series C in 2025
Abcuro, Inc. is a biotechnology company focused on developing immunotherapies for the treatment of autoimmunity and cancer. Based in Newton, Massachusetts, Abcuro creates therapeutic antibodies targeting novel mechanisms related to these diseases. The company utilizes advanced bioinformatics to analyze transcription data from human diseases, which aids in the identification of new therapeutic targets. Through ex-vivo validation in diseased tissues, Abcuro seeks to uncover innovative methods to modulate key components of the immune system. Established in 2015, Abcuro aims to enhance treatment strategies in the healthcare industry by offering effective solutions for complex immunological conditions.
VAST Data
Series E in 2023
VAST Data, Inc. specializes in developing innovative data storage solutions, offering a universal storage platform that integrates Intel’s Optane SSDs as a cache for data stored on quad-level cell (QLC) SSDs. Founded in 2016 and headquartered in New York, with an additional office in San Jose, VAST Data serves various industries, including animation, visual effects, deep learning, and enterprise backup recovery. The platform is designed to accelerate time-to-insight for workload-intensive applications, providing scalable performance, simple data management, and improved productivity for AI-driven organizations. Since its launch in 2019, VAST Data has gained recognition as a rapidly growing player in the data infrastructure sector.
Transfix
Series F in 2023
Transfix, Inc. is a trucking brokerage firm based in New York that specializes in connecting shippers with carriers for freight transportation across the United States. Founded in 2010, the company has developed an online freight management platform that utilizes advanced algorithms and business intelligence to enhance supply chain visibility and efficiency. Transfix offers services such as real-time shipment tracking, carrier performance insights, and support tailored to various industries, including retail, food, beverage, and manufacturing. By leveraging its Intelligent Freight Platform, Transfix aims to optimize logistics processes, reduce empty miles, and improve overall supply chain performance for its clients.
Pair Eyewear
Series C in 2023
Pair Eyewear, founded in 2017 and based in New York, specializes in customizable eyeglasses for children. The company offers a unique product line that includes base frames, which are standard glasses, and top frames, which are snap-on fronts that can be easily changed to reflect a child's evolving interests and personalities. By leveraging an e-commerce platform, Pair Eyewear aims to transform the eyeglass experience into an engaging activity for children while simplifying the process for parents. The brand focuses on quality and affordability, providing eyewear that combines style with functionality, featuring hand-polished acetate frames and shatterproof polycarbonate lenses.
X4 Pharmaceuticals
Post in 2022
X4 Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, dedicated to developing innovative therapies for primary immune deficiencies and cancer. The company's lead candidate, mavorixafor, is an oral small molecule antagonist of the chemokine receptor CXCR4, currently undergoing multiple clinical trials. It is in Phase III for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome, and in Phase Ib for severe congenital neutropenia and Waldenström macroglobulinemia. Additionally, mavorixafor is being explored in Phase IIa trials for clear cell renal cell carcinoma. X4 Pharmaceuticals is also advancing X4P-002, targeting glioblastoma multiforme, and X4P-003 for primary immune deficiencies. The company has partnered with Abbisko Therapeutics Co., Ltd. to develop mavorixafor in combination with checkpoint inhibitors for oncology applications. Founded in 2014, X4 Pharmaceuticals was previously known as Arsanis, Inc. and rebranded in March 2019.
Narmi
Series B in 2022
Narmi Inc. is a technology company based in New York that specializes in developing online and mobile banking applications for financial institutions across the United States. Founded in 2016, Narmi focuses on providing regional and community banks and credit unions with a platform that streamlines account opening processes, allowing clients to complete this in under 2.5 minutes. The company’s offerings include features such as fraud protection, multi-factor authentication, and transaction monitoring, which help enhance security and user experience. In addition to banking applications, Narmi also provides website design, development, and hosting services, as well as content generation and management solutions. Their goal is to enable financial institutions to attract, engage, and retain customers through an intuitive, omnichannel banking experience.
NODAR
Series A in 2022
NODAR, Inc. is a Boston-based company that specializes in manufacturing advanced sensors for various transportation modes, including cars, trucks, drones, ships, trains, and aircraft. Established in 2018, NODAR focuses on developing cutting-edge camera-based 3D vision systems aimed at enhancing the safety and reliability of autonomous vehicles. Their flagship product, Hammerhead, utilizes off-the-shelf cameras to deliver long-range, ultra-precise depth sensing essential for Level 3 and Level 4 autonomous applications. This technology enables critical functionalities such as collision warning, path planning, and automatic emergency braking, while ensuring cost-effectiveness and high performance. NODAR's innovations target automotive, marine, and railway industries, providing solutions that meet the growing demand for reliable 3D sensing technology in the mainstream automotive market.
Alfred
Venture Round in 2022
Founded in 2014 by Marcela Sapone and Jessica Beck, Alfred is the largest and most advanced residential management platform. Since its inception, Alfred has focused on providing a resident-first experience. With an unparalleled knowledge of what residents want and technology that boosts income and efficiency for owners and operators, Alfred provides a single stop that elevates the rental ecosystem for all involved. Named by Fast Company as one of the Top 50 Most Innovative Companies, Alfred’s AOS technology drives lower operating costs and higher returns for property owners and operators. Through strategic partnerships with international real-estate owners and operators such as Hines, Related, RXR, Greystar, Invesco, Brookfield and J.P. Morgan, With RKW, Alfred’s portfolio now extends to more than 300,000 residents in 44 cities across the U.S. and Canada and has planned expansions in Europe, Israel and Asia.
Beyond Identity
Series C in 2022
Beyond Identity, Inc. offers a cloud-native passwordless identity management platform that enhances secure authentication by replacing traditional passwords with X.509-based certificates. Founded in 2019 and based in New York, the company provides a comprehensive suite of features including frictionless login, biometric authentication, and Single Sign-On (SSO) integration for various users such as employees, contractors, and suppliers. Its innovative approach utilizes asymmetric-key cryptography to create a robust Chain of Trust, which incorporates user and device identities along with real-time security posture assessments for adaptive risk-based authentication. This technology not only improves security by eliminating credential-stuffing attacks but also facilitates increased business agility and efficiency, allowing organizations to adopt new business models and significantly reduce operational costs while achieving complete passwordless identity management.
Proof of Learn
Seed Round in 2022
Proof of Learn is a talent marketplace focused on educating and placing the next generation of developers. Founded in 2021 and based in Boston, the company operates Metacrafters.io, a multichain learn-to-earn platform that teaches users how to write smart contracts and build on-chain applications. The platform aims to provide equal access to education and job opportunities in the emerging Web3 space, utilizing blockchain technology to create a decentralized model for learning. By empowering learners to gain skills, earn rewards, and secure employment, Proof of Learn addresses the growing demand for qualified talent in the digital economy.
Pair Eyewear
Series B in 2021
Pair Eyewear, founded in 2017 and based in New York, specializes in customizable eyeglasses for children. The company offers a unique product line that includes base frames, which are standard glasses, and top frames, which are snap-on fronts that can be easily changed to reflect a child's evolving interests and personalities. By leveraging an e-commerce platform, Pair Eyewear aims to transform the eyeglass experience into an engaging activity for children while simplifying the process for parents. The brand focuses on quality and affordability, providing eyewear that combines style with functionality, featuring hand-polished acetate frames and shatterproof polycarbonate lenses.
Merge
Series A in 2021
Merge provides a comprehensive platform for B2B companies to streamline their integration processes through a single application programming interface (API). Founded in 2020, the company specializes in offering Unified APIs that facilitate secure data access across various software categories, such as human resources, accounting, customer relationship management, and file storage. Merge manages the complete integration lifecycle, from a swift initial setup to ongoing maintenance and observability tools, ensuring customer satisfaction. Its services help businesses enhance their operational efficiency by reducing customer churn, accelerating product development, and lowering engineering costs. Based in San Francisco, New York City, and Berlin, Merge has garnered significant support, receiving $75 million in funding from notable investors.
Attest
Series B in 2021
Attest is a consumer research platform headquartered in London and New York that specializes in delivering on-demand consumer insights to businesses. The platform allows users to engage directly with over 110 million consumers across more than 45 countries, facilitating market research in a matter of seconds. Attest provides an interface for conducting surveys that help validate product ideas and inform strategic decisions across various business aspects, including marketing, product development, and pricing. By enabling clients to build custom audiences and target specific demographics, Attest empowers businesses to address their growth challenges and make informed decisions based on real-time data and consumer feedback.
Clarifai
Series C in 2021
Clarifai, Inc. is a prominent provider of advanced artificial intelligence solutions specializing in image recognition, natural language processing, and audio recognition. Founded in 2013 by Matt Zeiler, Ph.D., the company develops a deep learning platform that enables organizations to convert unstructured data—such as images, videos, text, and audio—into structured data efficiently and accurately. Clarifai's image recognition technology is capable of detecting near-duplicates, categorizing objects, and tagging images, while also allowing users to search for similar images within extensive uncategorized collections through a combination of semantic and visual similarity. Additionally, the company offers a labeling tool called Labeler, which aids in dataset labeling, AI training, and model auto-scaling in production environments. Headquartered in New York, with an office in Tallinn, Estonia, Clarifai employs a distributed team across various countries, including the United States, Canada, Argentina, and India.
Wizard
Series A in 2021
Wizard is a New York-based commerce technology startup founded in 2021 that focuses on transforming e-commerce through conversational artificial intelligence (AI). The company develops software solutions that enable brands to sell and market their products directly via text messaging. This innovative approach allows clients to engage customers more effectively, resulting in higher conversion rates compared to traditional e-commerce methods.
Pager
Series C in 2021
Pager, Inc. operates an on-demand service platform that connects patients with healthcare services in various settings, including their homes, offices, and hotels. The company offers a mobile application that addresses urgent care needs such as infections, fevers, and allergies, while also providing services like nurse chat, teleconsultations, screening, vaccinations, and prescription delivery. Pager aims to improve healthcare access and decision-making by employing a flexible platform that serves health plans and systems, enhancing consumer experience through information, guidance, and coordination. By integrating clinical and service teams with advanced technology, Pager facilitates triage, telemedicine, appointment scheduling, and health advocacy, fostering a comprehensive care experience. The company, incorporated in 2013 and based in New York, supports over 15 million covered lives in the United States and Latin America.
Tulip Interfaces
Series C in 2021
Tulip Interfaces, Inc. specializes in creating applications for the manufacturing industry that enhance shop floor operations. Founded in 2012 and based in Somerville, Massachusetts, the company offers a no-code platform that allows organizations to integrate data from various sources, including sensors and existing equipment. This integration facilitates the creation of digital work instructions and provides real-time visibility into operations, including the performance of personnel and machinery. Tulip serves a diverse range of industries, including consumer electronics, pharmaceuticals, apparel, and medical devices, helping companies improve productivity, quality, and operational efficiency. By leveraging advanced technologies such as intelligent hardware sensors, computer vision, and machine learning, Tulip's platform enables organizations to digitally transform their operations and achieve better end-to-end traceability.
Vori Health
Series A in 2021
Vori Health is a healthcare provider focused on treating musculoskeletal conditions through an integrated care delivery model. Founded in 2020 and headquartered in New York, the organization offers a comprehensive range of services, including physical therapy, medical assessments, lab and imaging orders, health coaching, and nutritional guidance. Vori Health employs a virtual-first approach to connect patients with a collaborative care team, consisting of board-certified physical medicine physicians, health coach navigators, and physical therapists. This model aims to facilitate effective management of back, neck, and joint issues, guiding patients toward optimal wellness and recovery. By combining evidence-based practices with personalized support, Vori Health strives to improve patient outcomes in musculoskeletal care.
Merge
Seed Round in 2021
Merge provides a comprehensive platform for B2B companies to streamline their integration processes through a single application programming interface (API). Founded in 2020, the company specializes in offering Unified APIs that facilitate secure data access across various software categories, such as human resources, accounting, customer relationship management, and file storage. Merge manages the complete integration lifecycle, from a swift initial setup to ongoing maintenance and observability tools, ensuring customer satisfaction. Its services help businesses enhance their operational efficiency by reducing customer churn, accelerating product development, and lowering engineering costs. Based in San Francisco, New York City, and Berlin, Merge has garnered significant support, receiving $75 million in funding from notable investors.
Aetion
Series C in 2021
Aetion, Inc. is a healthcare analytics company that specializes in generating real-world evidence (RWE) through its Aetion Evidence Platform. This platform analyzes data from diverse clinical and financial interactions within the healthcare system, including claims, electronic health records, and clinical trials. By utilizing its patented rapid-cycle analytics technology, Aetion provides valuable insights to life sciences companies, payers, and healthcare providers, enabling them to assess the effectiveness and value of medical treatments. This facilitates collaboration among stakeholders to make informed decisions regarding patient care that is both clinically effective and cost-efficient. Founded in 2012 and headquartered in New York City, Aetion has established partnerships with various investors and organizations, including a strategic collaboration with McKesson. The company caters to a global clientele, including biopharmaceutical firms and academic institutions.
Vori Health
Series A in 2021
Vori Health is a healthcare provider focused on treating musculoskeletal conditions through an integrated care delivery model. Founded in 2020 and headquartered in New York, the organization offers a comprehensive range of services, including physical therapy, medical assessments, lab and imaging orders, health coaching, and nutritional guidance. Vori Health employs a virtual-first approach to connect patients with a collaborative care team, consisting of board-certified physical medicine physicians, health coach navigators, and physical therapists. This model aims to facilitate effective management of back, neck, and joint issues, guiding patients toward optimal wellness and recovery. By combining evidence-based practices with personalized support, Vori Health strives to improve patient outcomes in musculoskeletal care.
Moda Operandi
Venture Round in 2021
Moda Operandi is an online retailer based in New York that specializes in fashion products, offering a wide array of clothing, shoes, bags, jewelry, home goods, and accessories for men, women, and children. The company connects consumers directly with both established and emerging designers, facilitating the discovery of designer fashion through its platform. Moda Operandi features online trunk shows, allowing customers to preorder items from a curated selection of luxury brands and designers. In addition to serving consumers, the platform supports designers by providing them with a robust global network to help grow their businesses. The company was founded in 2010 and was previously known as Trunk Show Inc. before adopting its current name in August of that year.
Nuvolo
Series C in 2021
Nuvolo is an EAM platform that delivers a simple, intuitive, and user-friendly online and offline mobile experience. It is revolutionizing enterprise asset management by innovating on ServiceNow, an enterprise cloud platform. The company’s vision is to be the global leader in cloud-based EAM, powered by a culture of innovation and a relentless commitment to customer service. Fully optimized for growing, mobile workforces worldwide, Nuvolo delivers a simple, intuitive, and user-friendly online and offline mobile experience. It was founded in 2013 and is headquartered in Paramus, New Jersey with offices throughout the U.S. and internationally in London and Pune, India.
Burrow
Series C in 2021
Burrow, Inc. is a New York-based furniture company that designs, manufactures, and supplies a range of home furnishings, including customizable sofas, sectionals, loveseats, armchairs, and ottomans, as well as tables, rugs, and various accessories. Founded in 2016, Burrow focuses on creating luxury furniture that is both easy to move and comfortable, utilizing sustainably-sourced hardwood and non-toxic, scratch- and stain-resistant fabrics. The company aims to reinvent the home furnishing experience by offering personalized and durable products that allow customers to avoid traditional retail markups. Burrow sells its items through physical showrooms in several states, including Washington, Massachusetts, Texas, and California, as well as through its online platform. The company's manufacturing facility is located in Mexico City, Mexico.
Narmi
Series A in 2021
Narmi Inc. is a technology company based in New York that specializes in developing online and mobile banking applications for financial institutions across the United States. Founded in 2016, Narmi focuses on providing regional and community banks and credit unions with a platform that streamlines account opening processes, allowing clients to complete this in under 2.5 minutes. The company’s offerings include features such as fraud protection, multi-factor authentication, and transaction monitoring, which help enhance security and user experience. In addition to banking applications, Narmi also provides website design, development, and hosting services, as well as content generation and management solutions. Their goal is to enable financial institutions to attract, engage, and retain customers through an intuitive, omnichannel banking experience.
Beyond Identity
Series B in 2020
Beyond Identity, Inc. offers a cloud-native passwordless identity management platform that enhances secure authentication by replacing traditional passwords with X.509-based certificates. Founded in 2019 and based in New York, the company provides a comprehensive suite of features including frictionless login, biometric authentication, and Single Sign-On (SSO) integration for various users such as employees, contractors, and suppliers. Its innovative approach utilizes asymmetric-key cryptography to create a robust Chain of Trust, which incorporates user and device identities along with real-time security posture assessments for adaptive risk-based authentication. This technology not only improves security by eliminating credential-stuffing attacks but also facilitates increased business agility and efficiency, allowing organizations to adopt new business models and significantly reduce operational costs while achieving complete passwordless identity management.
DataRobot
Series F in 2020
DataRobot, Inc. develops an automated machine learning platform that empowers enterprises to create predictive models efficiently. Its offerings include DataRobot Cloud, a predictive analytics solution available both in the cloud and on-premises, and DataRobot MLOps, which facilitates the deployment, monitoring, and management of machine learning models across organizations. The company also provides DataRobot Enterprise, featuring flexible deployment options, governance, and training services, along with packages designed to accelerate artificial intelligence projects. DataRobot serves a diverse range of industries, including banking, healthcare, manufacturing, and marketing, catering to business analysts, data scientists, and IT professionals. Founded in 2012 and headquartered in Boston, Massachusetts, DataRobot has expanded its operations globally, with offices in major cities such as London, Paris, and Tokyo, and maintains strategic partnerships to enhance its offerings.
Alfred
Series C in 2020
Founded in 2014 by Marcela Sapone and Jessica Beck, Alfred is the largest and most advanced residential management platform. Since its inception, Alfred has focused on providing a resident-first experience. With an unparalleled knowledge of what residents want and technology that boosts income and efficiency for owners and operators, Alfred provides a single stop that elevates the rental ecosystem for all involved. Named by Fast Company as one of the Top 50 Most Innovative Companies, Alfred’s AOS technology drives lower operating costs and higher returns for property owners and operators. Through strategic partnerships with international real-estate owners and operators such as Hines, Related, RXR, Greystar, Invesco, Brookfield and J.P. Morgan, With RKW, Alfred’s portfolio now extends to more than 300,000 residents in 44 cities across the U.S. and Canada and has planned expansions in Europe, Israel and Asia.
Illusive Networks
Series B in 2020
Illusive Networks Ltd. specializes in developing cybersecurity solutions focused on deception technology to prevent cyber attacks on enterprise systems. By creating a deceptive environment within existing networks, Illusive effectively identifies attackers, disrupts their activities, and provides actionable forensic insights. The company's offerings include compliance support, insider threat defense, and cloud security services, along with a comprehensive management platform that integrates various modular components for centralized cybersecurity management. Its Active Defense technology enhances security by removing vulnerable connections and replacing them with deceptive alternatives, allowing organizations to detect advanced persistent threats and prevent lateral movement by attackers. Founded in 2014 and based in Tel Aviv-Yafo, Israel, with an additional office in New York, Illusive serves clients across several industries, including finance, healthcare, legal, manufacturing, retail, and technology. The company, spun out from the venture group Team8, leverages expertise from veterans of Israel’s military intelligence to support its innovative approach to cybersecurity.
Korro Bio
Series A in 2020
Korro Bio Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, that specializes in developing nucleic acid-based therapeutics aimed at editing RNA to treat rare and prevalent diseases. Founded in 2018, the company has created a proprietary platform that allows for efficient and selective RNA editing, leveraging natural processes found in multicellular organisms. This innovative approach enables precise modifications to messenger RNA, allowing for targeted changes in protein structure and function across various tissues. By focusing on RNA instead of DNA, Korro Bio aims to enhance the precision and adaptability of genetic medicines, expanding their potential applications in treating a range of medical conditions.
Maisonette
Series B in 2020
Maisonette Inc. is an online marketplace that specializes in baby and children's products, offering a curated selection of fashion, accessories, toys, furniture, and home decor for children aged 0-12. Established in 2016 and based in Brooklyn, New York, Maisonette aggregates a diverse range of quality items from a global network of brands and boutiques. This platform serves as a one-stop shopping destination for parents, providing them with a unified portal to access style-driven products at various price points, thereby simplifying the shopping experience for children's lifestyle needs.
Attest
Venture Round in 2020
Attest is a consumer research platform headquartered in London and New York that specializes in delivering on-demand consumer insights to businesses. The platform allows users to engage directly with over 110 million consumers across more than 45 countries, facilitating market research in a matter of seconds. Attest provides an interface for conducting surveys that help validate product ideas and inform strategic decisions across various business aspects, including marketing, product development, and pricing. By enabling clients to build custom audiences and target specific demographics, Attest empowers businesses to address their growth challenges and make informed decisions based on real-time data and consumer feedback.
Beyond Identity
Series A in 2020
Beyond Identity, Inc. offers a cloud-native passwordless identity management platform that enhances secure authentication by replacing traditional passwords with X.509-based certificates. Founded in 2019 and based in New York, the company provides a comprehensive suite of features including frictionless login, biometric authentication, and Single Sign-On (SSO) integration for various users such as employees, contractors, and suppliers. Its innovative approach utilizes asymmetric-key cryptography to create a robust Chain of Trust, which incorporates user and device identities along with real-time security posture assessments for adaptive risk-based authentication. This technology not only improves security by eliminating credential-stuffing attacks but also facilitates increased business agility and efficiency, allowing organizations to adopt new business models and significantly reduce operational costs while achieving complete passwordless identity management.
Affinia Therapeutics
Series A in 2020
Affinia Therapeutics Inc. is focused on developing gene therapies for various diseases, particularly those affecting the muscles and central nervous system. The company specializes in creating adeno-associated virus (AAV) vectors, leveraging advanced techniques in synthetic and systems biology, as well as high-throughput screening and tissue and single-cell resolution. Founded in 2019 and based in Waltham, Massachusetts, Affinia aims to address significant unmet medical needs by providing rationally designed gene therapies with improved properties. The company's innovative approach seeks to offer effective treatments for devastating conditions that currently lack adequate therapeutic options.
Pager
Series B in 2020
Pager, Inc. operates an on-demand service platform that connects patients with healthcare services in various settings, including their homes, offices, and hotels. The company offers a mobile application that addresses urgent care needs such as infections, fevers, and allergies, while also providing services like nurse chat, teleconsultations, screening, vaccinations, and prescription delivery. Pager aims to improve healthcare access and decision-making by employing a flexible platform that serves health plans and systems, enhancing consumer experience through information, guidance, and coordination. By integrating clinical and service teams with advanced technology, Pager facilitates triage, telemedicine, appointment scheduling, and health advocacy, fostering a comprehensive care experience. The company, incorporated in 2013 and based in New York, supports over 15 million covered lives in the United States and Latin America.
Akouos
Series B in 2020
Akouos, Inc. is a biotechnology company based in Boston, Massachusetts, dedicated to developing gene therapies aimed at restoring, improving, and preserving hearing for individuals affected by various inner ear disorders. Founded in 2016, the company utilizes an innovative platform that includes a proprietary adeno-associated viral vector library and a unique delivery method. Its leading product candidate, AK-OTOF, targets hearing loss resulting from mutations in the OTOF gene. Akouos focuses on genetically-defined patient populations, addressing conditions ranging from single genetic mutations to hearing loss caused by ototoxic drugs and aging. The company has established strategic partnerships with key institutions, including Massachusetts Eye and Ear and Lonza, Inc., to advance its mission of providing precision genetic therapies for sensorineural hearing loss.
Moda Operandi
Venture Round in 2020
Moda Operandi is an online retailer based in New York that specializes in fashion products, offering a wide array of clothing, shoes, bags, jewelry, home goods, and accessories for men, women, and children. The company connects consumers directly with both established and emerging designers, facilitating the discovery of designer fashion through its platform. Moda Operandi features online trunk shows, allowing customers to preorder items from a curated selection of luxury brands and designers. In addition to serving consumers, the platform supports designers by providing them with a robust global network to help grow their businesses. The company was founded in 2010 and was previously known as Trunk Show Inc. before adopting its current name in August of that year.
Moda Operandi
Debt Financing in 2020
Moda Operandi is an online retailer based in New York that specializes in fashion products, offering a wide array of clothing, shoes, bags, jewelry, home goods, and accessories for men, women, and children. The company connects consumers directly with both established and emerging designers, facilitating the discovery of designer fashion through its platform. Moda Operandi features online trunk shows, allowing customers to preorder items from a curated selection of luxury brands and designers. In addition to serving consumers, the platform supports designers by providing them with a robust global network to help grow their businesses. The company was founded in 2010 and was previously known as Trunk Show Inc. before adopting its current name in August of that year.
Black Diamond Therapeutics
Series C in 2019
Black Diamond Therapeutics is a precision oncology medicine company focused on discovering and developing small molecule therapies that are tumor-agnostic. The company’s lead product candidate, BDTX-189, targets non-canonical and oncogenic mutations in ErbB kinases, specifically the epidermal growth factor receptor and tyrosine-protein kinase. In addition to BDTX-189, Black Diamond is developing allosteric-EGFR mutation inhibitors and other early-stage pipeline programs that address allosteric mutations in kinases associated with cancer and rare genetic diseases. The company's approach is centered on its Mutation-Allostery-Pharmacology platform, which aims to create targeted treatments for genetically defined cancers, especially for patients with limited existing treatment options. Founded in 2014 and headquartered in Cambridge, Massachusetts, Black Diamond Therapeutics was previously known as ASET Therapeutics until its name change in January 2018.
The Yes
Series A in 2019
They are co-located in Silicon Valley and New York City, but are open to great talent anywhere. They welcome critical thinkers who are excited to re-write the rules of e-commerce. They promise it will be fun.
DataRobot
Series E in 2019
DataRobot, Inc. develops an automated machine learning platform that empowers enterprises to create predictive models efficiently. Its offerings include DataRobot Cloud, a predictive analytics solution available both in the cloud and on-premises, and DataRobot MLOps, which facilitates the deployment, monitoring, and management of machine learning models across organizations. The company also provides DataRobot Enterprise, featuring flexible deployment options, governance, and training services, along with packages designed to accelerate artificial intelligence projects. DataRobot serves a diverse range of industries, including banking, healthcare, manufacturing, and marketing, catering to business analysts, data scientists, and IT professionals. Founded in 2012 and headquartered in Boston, Massachusetts, DataRobot has expanded its operations globally, with offices in major cities such as London, Paris, and Tokyo, and maintains strategic partnerships to enhance its offerings.
Burrow
Series B in 2019
Burrow, Inc. is a New York-based furniture company that designs, manufactures, and supplies a range of home furnishings, including customizable sofas, sectionals, loveseats, armchairs, and ottomans, as well as tables, rugs, and various accessories. Founded in 2016, Burrow focuses on creating luxury furniture that is both easy to move and comfortable, utilizing sustainably-sourced hardwood and non-toxic, scratch- and stain-resistant fabrics. The company aims to reinvent the home furnishing experience by offering personalized and durable products that allow customers to avoid traditional retail markups. Burrow sells its items through physical showrooms in several states, including Washington, Massachusetts, Texas, and California, as well as through its online platform. The company's manufacturing facility is located in Mexico City, Mexico.
Nuvolo
Series B in 2019
Nuvolo is an EAM platform that delivers a simple, intuitive, and user-friendly online and offline mobile experience. It is revolutionizing enterprise asset management by innovating on ServiceNow, an enterprise cloud platform. The company’s vision is to be the global leader in cloud-based EAM, powered by a culture of innovation and a relentless commitment to customer service. Fully optimized for growing, mobile workforces worldwide, Nuvolo delivers a simple, intuitive, and user-friendly online and offline mobile experience. It was founded in 2013 and is headquartered in Paramus, New Jersey with offices throughout the U.S. and internationally in London and Pune, India.
Tamara Mellon
Series C in 2019
Tamara Mellon, LLC specializes in offering women's apparel and accessories, including a diverse range of footwear such as sandals, boots, pumps, flats, and legging boots. The company also features designer handbags and ready-to-wear clothing, which encompasses dresses, jumpsuits, tops, knitwear, pants, skirts, and outerwear. Founded in 2011 by Tamara Mellon and Jill Layfield, the company is headquartered in New York City and sells its products through both retail and online channels in the United States and internationally. In addition to its fashion offerings, Tamara Mellon provides a complimentary cobbler service for two years after purchase, enhancing the customer experience by ensuring the durability and maintenance of its handcrafted footwear.
Intact Vascular
Series D in 2019
Intact Vascular, Inc. is a medical device company based in Wayne, Pennsylvania, focused on developing minimally invasive products for peripheral vascular procedures. Established in 2011, the company is known for its Tack Endovascular System, which enhances the results of peripheral balloon angioplasty in treating peripheral arterial disease (PAD) and critical limb ischemia (CLI). This innovative technology aims to improve clinical outcomes and quality of life for patients suffering from vascular diseases, offering physicians a new and effective treatment option. Intact Vascular is dedicated to creating safe, efficacious, and user-friendly medical devices for healthcare providers and their patients.
Vesper Medical
Venture Round in 2019
Vesper Medical is committed to developing safe, efficacious and easy-to-use products for patients with deep venous disease and the physicians who treat them. The company's core technology, the Vesper DUO Venous Stent System, is purpose-built for venous stenting, with an unmatched combination of strength and flexibility designed to meet the multiple anatomical challenges presented by vein mechanics. Vesper Medical is advancing the treatment of deep venous disease by creating a highly differentiated, purpose-built venous stent portfolio that addresses the multiple anatomical challenges presented by the iliac and femoral veins. It also develops minimally- invasive peripheral vascular products. Vesper Medical was founded in 2016 and is headquartered in Wayne, PA, USA.
Mejuri
Series B in 2019
Mejuri Inc. is a Canadian company that specializes in the manufacture and sale of fine jewelry, including rings, necklaces, earrings, bracelets, and engagement pieces. Founded in 2015 and headquartered in Toronto, Mejuri operates showrooms in New York, Toronto, and Chicago, while also offering its products through a direct-to-consumer e-commerce platform. This model allows Mejuri to provide quality handcrafted jewelry at accessible prices by eliminating middlemen and maintaining a fast supply chain that introduces new designs weekly. Committed to exceptional craftsmanship and ethical practices, Mejuri aims to empower women to incorporate luxury into their everyday lives. The company serves customers not only in Canada and the United States but also internationally.
Attest
Series A in 2019
Attest is a consumer research platform headquartered in London and New York that specializes in delivering on-demand consumer insights to businesses. The platform allows users to engage directly with over 110 million consumers across more than 45 countries, facilitating market research in a matter of seconds. Attest provides an interface for conducting surveys that help validate product ideas and inform strategic decisions across various business aspects, including marketing, product development, and pricing. By enabling clients to build custom audiences and target specific demographics, Attest empowers businesses to address their growth challenges and make informed decisions based on real-time data and consumer feedback.
Casper
Series D in 2019
Casper is a sleep startup that launches a comfortable mattress sold directly to consumers, eliminating commission driven, inflated prices. Casper's mattresses are developed in-house by a team of product engineers with experience from IDEO. The company developed a line of core sleep products, including the Casper pillow, sheets, foundation, bed frame, duvet, and a dog mattress. The startup was founded in 2014 and is based in New York, United States.
Imara
Series B in 2019
Imara, Inc. is a clinical-stage biopharmaceutical company based in Boston, Massachusetts, focused on developing and commercializing therapeutics for rare genetic disorders of hemoglobin, including sickle cell disease and beta-thalassemia. Founded in 2016, the company is advancing its lead product candidate, IMR-687, which is a highly selective small molecule inhibitor of PDE9. IMR-687 is designed as an oral, once-a-day treatment that aims to modify disease through a multimodal mechanism of action affecting various cell types, including red and white blood cells. Imara is dedicated to addressing the unmet medical needs of patients suffering from these serious hemoglobinopathies.
Luminary Media
Venture Round in 2019
Luminary Media, LLC is a subscription-based audio entertainment company that specializes in podcasting. Founded in 2018 and headquartered in New York, the company provides a platform for users to search and listen to a variety of podcasts, including original shows from notable podcasters and entertainers, all without advertisements. Luminary Media aims to create a comprehensive podcast ecosystem that connects listeners and creators, offering an elegantly designed platform that emphasizes innovation in the audio entertainment space.
Landit
Series A in 2019
Landit, Inc. operates a talent management platform focused on supporting women and diverse groups in the workplace. Founded in 2014 and based in New York, the company offers a personalized career development solution that helps organizations attract, develop, and retain high-potential talent. Landit's platform provides each member with a tailored playbook that includes tools, resources, executive coaching, and connections essential for professional growth. Key features of the platform encompass building personal brands, creating personal advisory boards, and facilitating curated skill development aligned with career opportunities. Through these offerings, Landit aims to enhance the success and engagement of women and diverse individuals in their careers.
Tulip Interfaces
Series B in 2019
Tulip Interfaces, Inc. specializes in creating applications for the manufacturing industry that enhance shop floor operations. Founded in 2012 and based in Somerville, Massachusetts, the company offers a no-code platform that allows organizations to integrate data from various sources, including sensors and existing equipment. This integration facilitates the creation of digital work instructions and provides real-time visibility into operations, including the performance of personnel and machinery. Tulip serves a diverse range of industries, including consumer electronics, pharmaceuticals, apparel, and medical devices, helping companies improve productivity, quality, and operational efficiency. By leveraging advanced technologies such as intelligent hardware sensors, computer vision, and machine learning, Tulip's platform enables organizations to digitally transform their operations and achieve better end-to-end traceability.
Aetion
Series B in 2019
Aetion, Inc. is a healthcare analytics company that specializes in generating real-world evidence (RWE) through its Aetion Evidence Platform. This platform analyzes data from diverse clinical and financial interactions within the healthcare system, including claims, electronic health records, and clinical trials. By utilizing its patented rapid-cycle analytics technology, Aetion provides valuable insights to life sciences companies, payers, and healthcare providers, enabling them to assess the effectiveness and value of medical treatments. This facilitates collaboration among stakeholders to make informed decisions regarding patient care that is both clinically effective and cost-efficient. Founded in 2012 and headquartered in New York City, Aetion has established partnerships with various investors and organizations, including a strategic collaboration with McKesson. The company caters to a global clientele, including biopharmaceutical firms and academic institutions.
Black Diamond Therapeutics
Series B in 2019
Black Diamond Therapeutics is a precision oncology medicine company focused on discovering and developing small molecule therapies that are tumor-agnostic. The company’s lead product candidate, BDTX-189, targets non-canonical and oncogenic mutations in ErbB kinases, specifically the epidermal growth factor receptor and tyrosine-protein kinase. In addition to BDTX-189, Black Diamond is developing allosteric-EGFR mutation inhibitors and other early-stage pipeline programs that address allosteric mutations in kinases associated with cancer and rare genetic diseases. The company's approach is centered on its Mutation-Allostery-Pharmacology platform, which aims to create targeted treatments for genetically defined cancers, especially for patients with limited existing treatment options. Founded in 2014 and headquartered in Cambridge, Massachusetts, Black Diamond Therapeutics was previously known as ASET Therapeutics until its name change in January 2018.
Trevi Therapeutics
Series C in 2019
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, dedicated to developing and commercializing nalbuphine ER, an oral extended-release formulation. The company is focused on treating serious neurologically mediated conditions, specifically chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in individuals with Parkinson's disease. Trevi is currently conducting a Phase 2b/3 clinical trial, known as the PRISM trial, for nalbuphine ER, targeting severe pruritus associated with prurigo nodularis. The conditions being addressed share similar underlying mechanisms that involve opioid receptors in both the central and peripheral nervous systems. Founded in 2011, Trevi Therapeutics aims to provide innovative treatment options for patients suffering from these challenging health issues.
Lungpacer Medical
Venture Round in 2019
Lungpacer Medical Inc. is a medical device company specializing in therapeutic solutions aimed at enhancing the treatment of critically ill patients who require mechanical ventilation. Founded in 2009 and headquartered in Vancouver, Canada, with an additional office in Exton, Pennsylvania, the company has developed the Lungpacer DPT System. This diaphragm pacing system utilizes a temporary, minimally invasive, transvascular nerve stimulation technique to activate the diaphragm muscle, preserving its strength and integrity. By addressing the significant health and cost challenges associated with mechanical ventilation in Intensive Care Units, Lungpacer Medical aims to improve patient outcomes and reduce hospital care costs. The technology is designed to restore negative pressure ventilation, offering a more physiological respiratory pattern and mitigating the harmful effects associated with positive pressure ventilation.
The Wing
Series C in 2018
The Wing is a network of work and community spaces designed for women with locations in New York, California, and Washington, D.C. The Wing’s mission is the professional, civic, social, and economic advancement of women through the community.
Transfix
Series D in 2018
Transfix, Inc. is a trucking brokerage firm based in New York that specializes in connecting shippers with carriers for freight transportation across the United States. Founded in 2010, the company has developed an online freight management platform that utilizes advanced algorithms and business intelligence to enhance supply chain visibility and efficiency. Transfix offers services such as real-time shipment tracking, carrier performance insights, and support tailored to various industries, including retail, food, beverage, and manufacturing. By leveraging its Intelligent Freight Platform, Transfix aims to optimize logistics processes, reduce empty miles, and improve overall supply chain performance for its clients.
DataRobot
Series D in 2018
DataRobot, Inc. develops an automated machine learning platform that empowers enterprises to create predictive models efficiently. Its offerings include DataRobot Cloud, a predictive analytics solution available both in the cloud and on-premises, and DataRobot MLOps, which facilitates the deployment, monitoring, and management of machine learning models across organizations. The company also provides DataRobot Enterprise, featuring flexible deployment options, governance, and training services, along with packages designed to accelerate artificial intelligence projects. DataRobot serves a diverse range of industries, including banking, healthcare, manufacturing, and marketing, catering to business analysts, data scientists, and IT professionals. Founded in 2012 and headquartered in Boston, Massachusetts, DataRobot has expanded its operations globally, with offices in major cities such as London, Paris, and Tokyo, and maintains strategic partnerships to enhance its offerings.
Forter
Series D in 2018
Forter, Inc. specializes in providing automated fraud prevention solutions for online merchants, aimed at creating a secure e-commerce environment. Founded in 2013 and headquartered in New York, with additional offices in London and Tel Aviv, the company offers a comprehensive platform that employs machine learning and various data analysis techniques to accurately assess transaction risks. Its Decision-As-a-Service system evaluates each transaction by analyzing multiple data points, leveraging cyber intelligence, and assessing customer behavior to deliver informed fraud decisions. Forter also features Smart Routing, which optimizes payment processing to minimize revenue loss from false declines. By focusing on a consumer-centric approach, Forter enhances approval rates, thereby improving the overall customer experience while effectively combating issues such as credit card fraud and identity theft.
Enigma
Series C in 2018
Enigma Technologies, Inc. is a New York-based operational data management and intelligence company that focuses on providing a searchable database of public records and information to enhance decision-making and streamline operations. The company offers a suite of products including Enigma Data Infrastructure, which features tools for data operations and metadata improvement, and Enigma Solutions tailored for industries such as financial services, healthcare, and insurance. Additionally, Enigma provides analysis-ready public data across various sectors, as well as a repository of public information. Enigma Labs fosters collaboration to develop open data tools for public use, while the company’s application programming interface (API) enables developers to create data-rich applications and services. Enigma's offerings also include specialized data services like entity resolution and geocoding. Founded in 2011, Enigma serves notable organizations such as American Express and PayPal, providing insights into the identity, activity, and risk profiles of small businesses.
PhaseBio
Series D in 2018
PhaseBio is a clinical-stage biopharmaceutical company focused on developing innovative therapies for endocrine and metabolic disorders, as well as cardiovascular diseases. The company leverages its proprietary elastin-like polypeptides (ELPs) technology to enhance the stability, bioavailability, and efficacy of proteins and peptides. Its lead candidate, PB1023, is in a phase 2b clinical trial for managing hyperglycemia in type 2 diabetes, with potential applications in obesity. Additionally, PhaseBio is advancing Vasomera, a candidate in phase 1 trials aimed at treating pulmonary arterial hypertension and heart failure. The company is also exploring PB2452, a novel reversal agent for the antiplatelet drug ticagrelor, and PB1046 for pulmonary arterial hypertension. With a commitment to addressing unmet medical needs, PhaseBio is headquartered in Malvern, Pennsylvania.
Formlabs
Series D in 2018
Formlabs Inc. is a company that designs and manufactures advanced 3D printing systems targeted at engineers, designers, and artists. Established in 2011 and headquartered in Somerville, Massachusetts, Formlabs offers a diverse range of products, including the Form 3, Form 3B, and Form 3L printers, all utilizing Low Force Stereolithography (LFS) technology. The company also provides post-processing solutions such as Form Wash and Form Cure, as well as the Fuse 1 SLS 3D printer and the Form Cell manufacturing solution. Formlabs develops high-performance materials for various applications in industries like dental, healthcare, jewelry, and education. Its PreForm software facilitates the preparation of models for printing, making it a preferred choice among professionals worldwide. With additional offices in Germany, Japan, China, Singapore, Hungary, and North Carolina, Formlabs continues to innovate in the field of 3D printing, enhancing the capabilities of digital fabrication.
Tamr
Series B in 2018
Tamr, Inc. is an enterprise data unification company that specializes in providing data management solutions. The company offers a platform that utilizes machine learning combined with human expertise to identify and integrate diverse internal and external data sources, thereby enabling organizations to manage siloed data effectively. Tamr's services include enterprise data preparation, clinical data conversion, procurement optimization, and customer data integration, catering to various sectors such as financial services, life sciences, government, and manufacturing. Founded in 2013 by experienced professionals in the database industry, Tamr is headquartered in Cambridge, Massachusetts, with additional offices in major cities including New York, Seattle, San Francisco, Washington, D.C., and London. The company aims to deliver valuable insights from data, supporting clients in achieving successful business outcomes.
Automation Anywhere
Series A in 2018
Automation Anywhere, Inc. is a global leader in Robotic Process Automation (RPA), specializing in AI-powered software solutions that automate repetitive business tasks. The company's cloud-native platform integrates RPA with artificial intelligence, machine learning, and analytics to improve productivity, customer experience, and employee engagement. Key offerings include Automation Anywhere Enterprise, which automates IT and business processes; Automation Anywhere Server; and the Premier application for creating and managing automation visually. The company also provides solutions like Process inVision for documenting processes and various Testing Anywhere products for quality assurance across multiple platforms. Additionally, Automation Anywhere offers consulting services and has established a strategic partnership with Microsoft Azure. Founded in 2003 and headquartered in San Jose, California, the company operates offices in major global cities, including Boston, Dallas, New York, and various locations in Asia and Europe.
Catalog
Seed Round in 2018
Catalog is a developer of a data conversion and storage platform used to offer the next generation of digital data archives and computation. Its platform facilitates the encoding of data and information into DNA format and makes it economically attractive to use DNA as the major medium for long-term archival of data that enables customers to store digital information in DNA molecules. It brings cutting-edge synthetic biology technologies to the world of information storage and computation. The company was founded in 2016 and is headquartered in Boston, Massachusetts.
Alfred
Series B in 2018
Founded in 2014 by Marcela Sapone and Jessica Beck, Alfred is the largest and most advanced residential management platform. Since its inception, Alfred has focused on providing a resident-first experience. With an unparalleled knowledge of what residents want and technology that boosts income and efficiency for owners and operators, Alfred provides a single stop that elevates the rental ecosystem for all involved. Named by Fast Company as one of the Top 50 Most Innovative Companies, Alfred’s AOS technology drives lower operating costs and higher returns for property owners and operators. Through strategic partnerships with international real-estate owners and operators such as Hines, Related, RXR, Greystar, Invesco, Brookfield and J.P. Morgan, With RKW, Alfred’s portfolio now extends to more than 300,000 residents in 44 cities across the U.S. and Canada and has planned expansions in Europe, Israel and Asia.
Dreams
Series A in 2018
Dreams is a mobile-only television platform that reimagines the news experience for mobile devices. Founded in 2016 in New York City by Tom Bender and Greg Hochmuth, the company has developed patent-pending computer vision technology that converts live TV news into a vertical video format in real-time. This innovation allows for the creation of live, 24/7 vertical video news channels, catering to the increasing demand for mobile-friendly content. The Dreams app is available for free in the U.S. on both the App Store and Google Play, and it does not require any login or registration to access its features.
Luminary Media
Venture Round in 2018
Luminary Media, LLC is a subscription-based audio entertainment company that specializes in podcasting. Founded in 2018 and headquartered in New York, the company provides a platform for users to search and listen to a variety of podcasts, including original shows from notable podcasters and entertainers, all without advertisements. Luminary Media aims to create a comprehensive podcast ecosystem that connects listeners and creators, offering an elegantly designed platform that emphasizes innovation in the audio entertainment space.
Tamara Mellon
Series B in 2018
Tamara Mellon, LLC specializes in offering women's apparel and accessories, including a diverse range of footwear such as sandals, boots, pumps, flats, and legging boots. The company also features designer handbags and ready-to-wear clothing, which encompasses dresses, jumpsuits, tops, knitwear, pants, skirts, and outerwear. Founded in 2011 by Tamara Mellon and Jill Layfield, the company is headquartered in New York City and sells its products through both retail and online channels in the United States and internationally. In addition to its fashion offerings, Tamara Mellon provides a complimentary cobbler service for two years after purchase, enhancing the customer experience by ensuring the durability and maintenance of its handcrafted footwear.
Intact Vascular
Series C in 2018
Intact Vascular, Inc. is a medical device company based in Wayne, Pennsylvania, focused on developing minimally invasive products for peripheral vascular procedures. Established in 2011, the company is known for its Tack Endovascular System, which enhances the results of peripheral balloon angioplasty in treating peripheral arterial disease (PAD) and critical limb ischemia (CLI). This innovative technology aims to improve clinical outcomes and quality of life for patients suffering from vascular diseases, offering physicians a new and effective treatment option. Intact Vascular is dedicated to creating safe, efficacious, and user-friendly medical devices for healthcare providers and their patients.
Aetion
Series B in 2018
Aetion, Inc. is a healthcare analytics company that specializes in generating real-world evidence (RWE) through its Aetion Evidence Platform. This platform analyzes data from diverse clinical and financial interactions within the healthcare system, including claims, electronic health records, and clinical trials. By utilizing its patented rapid-cycle analytics technology, Aetion provides valuable insights to life sciences companies, payers, and healthcare providers, enabling them to assess the effectiveness and value of medical treatments. This facilitates collaboration among stakeholders to make informed decisions regarding patient care that is both clinically effective and cost-efficient. Founded in 2012 and headquartered in New York City, Aetion has established partnerships with various investors and organizations, including a strategic collaboration with McKesson. The company caters to a global clientele, including biopharmaceutical firms and academic institutions.
Burrow
Series A in 2018
Burrow, Inc. is a New York-based furniture company that designs, manufactures, and supplies a range of home furnishings, including customizable sofas, sectionals, loveseats, armchairs, and ottomans, as well as tables, rugs, and various accessories. Founded in 2016, Burrow focuses on creating luxury furniture that is both easy to move and comfortable, utilizing sustainably-sourced hardwood and non-toxic, scratch- and stain-resistant fabrics. The company aims to reinvent the home furnishing experience by offering personalized and durable products that allow customers to avoid traditional retail markups. Burrow sells its items through physical showrooms in several states, including Washington, Massachusetts, Texas, and California, as well as through its online platform. The company's manufacturing facility is located in Mexico City, Mexico.
CoEdition
Seed Round in 2018
CoEdition, Inc. is an online retailer focused on providing a diverse range of women's clothing, shoes, and jewelry, specifically catering to sizes 10 to 26. The company offers a wide selection of products, including dresses, swimwear, footwear, lingerie, and accessories, sourced from over 100 brands. Established in 2017 and headquartered in New York, CoEdition aims to create an inclusive fashion marketplace that allows women to discover and purchase contemporary apparel at affordable prices. Through its e-commerce platform, CoEdition seeks to empower women by enabling them to express their personal style while accessing a community dedicated to plus-size fashion.
Upskill
Corporate Round in 2018
Upskill, Inc. specializes in designing and developing augmented reality software tailored for the industrial workforce. The company's flagship platform, Skylight, empowers businesses to create applications for smart glasses, facilitating enhanced communication and access to information for hands-on workers across various sectors, such as manufacturing, healthcare, logistics, and military. By connecting workers to essential processes, tools, and data, Skylight aims to improve operational efficiency, reduce errors, and streamline training for new employees. Upskill's innovative solutions enable organizations to increase productivity, enhance quality, and maintain competitiveness in a rapidly evolving market. Founded in 2010 and based in Vienna, Virginia, with additional offices in Cambridge and San Francisco, Upskill was formerly known as APX Labs before rebranding in 2017.
Vizbee
Venture Round in 2018
Vizbee Inc., founded in 2014 and based in New York, operates within the technology sector. The company specializes in integrating mobile and streaming devices into a cohesive application that enhances user experience at home. Vizbee transforms traditional mobile marketing channels into direct response pathways for television viewers, facilitating a more interactive and engaging viewing experience. Additionally, the company offers a solution called Homegraph, which automatically organizes connected streaming devices, thereby unifying user acquisition and retention across different devices.
Pager
Series A in 2018
Pager, Inc. operates an on-demand service platform that connects patients with healthcare services in various settings, including their homes, offices, and hotels. The company offers a mobile application that addresses urgent care needs such as infections, fevers, and allergies, while also providing services like nurse chat, teleconsultations, screening, vaccinations, and prescription delivery. Pager aims to improve healthcare access and decision-making by employing a flexible platform that serves health plans and systems, enhancing consumer experience through information, guidance, and coordination. By integrating clinical and service teams with advanced technology, Pager facilitates triage, telemedicine, appointment scheduling, and health advocacy, fostering a comprehensive care experience. The company, incorporated in 2013 and based in New York, supports over 15 million covered lives in the United States and Latin America.
Centrexion Therapeutics
Series D in 2018
Centrexion Therapeutics Corporation is a late clinical-stage biopharmaceutical company based in Boston, Massachusetts, dedicated to developing non-opioid and non-addictive therapies aimed at addressing chronic pain. The company's product pipeline includes CNTX-4975, currently in Phase III trials for moderate to severe knee osteoarthritis pain, and in Phase II trials for Morton’s neuroma and canine osteoarthritis. Additionally, CNTX-0290 is in Phase I trials targeting chronic pain associated with inflammatory, neuropathic, and mixed conditions. Other candidates under development include CNTX-6970, for inflammatory pain, and CNTX-2022, a high-concentration topical gel formulation of lidocaine for various types of pain. CNTX-6016 is also in pre-clinical stages focusing on chronic neuropathic pain. Founded in 2013, Centrexion Therapeutics aims to provide safe and effective solutions for patients suffering from chronic pain conditions.
Korro Bio
Seed Round in 2018
Korro Bio Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, that specializes in developing nucleic acid-based therapeutics aimed at editing RNA to treat rare and prevalent diseases. Founded in 2018, the company has created a proprietary platform that allows for efficient and selective RNA editing, leveraging natural processes found in multicellular organisms. This innovative approach enables precise modifications to messenger RNA, allowing for targeted changes in protein structure and function across various tissues. By focusing on RNA instead of DNA, Korro Bio aims to enhance the precision and adaptability of genetic medicines, expanding their potential applications in treating a range of medical conditions.
Akouos
Seed Round in 2017
Akouos, Inc. is a biotechnology company based in Boston, Massachusetts, dedicated to developing gene therapies aimed at restoring, improving, and preserving hearing for individuals affected by various inner ear disorders. Founded in 2016, the company utilizes an innovative platform that includes a proprietary adeno-associated viral vector library and a unique delivery method. Its leading product candidate, AK-OTOF, targets hearing loss resulting from mutations in the OTOF gene. Akouos focuses on genetically-defined patient populations, addressing conditions ranging from single genetic mutations to hearing loss caused by ototoxic drugs and aging. The company has established strategic partnerships with key institutions, including Massachusetts Eye and Ear and Lonza, Inc., to advance its mission of providing precision genetic therapies for sensorineural hearing loss.
The Wing
Series B in 2017
The Wing is a network of work and community spaces designed for women with locations in New York, California, and Washington, D.C. The Wing’s mission is the professional, civic, social, and economic advancement of women through the community.
Ursa Space Systems
Series A in 2017
Ursa Space Systems Inc. is a geospatial services company that provides aerial and space-based data products to enhance geographic mapping and location-based information. Its offerings include imagery and information products that support market and weather forecasting, agricultural yield improvement, disaster response, and military intelligence. The company is known for its Ursa Global Oil Storage Monitoring solution, which provides insights into global oil storage for hedge funds, commodities traders, banks, and oil companies. Ursa Space Systems serves various sectors, including precision agriculture, business intelligence, weather monitoring, humanitarian relief, civil protection, mapping, and traffic applications. Founded in 2014, the company is headquartered in Ithaca, New York, and leverages radar satellite data to deliver timely reports, fostering transparency in global markets for the finance and energy industries.
DataRobot
Series C in 2017
DataRobot, Inc. develops an automated machine learning platform that empowers enterprises to create predictive models efficiently. Its offerings include DataRobot Cloud, a predictive analytics solution available both in the cloud and on-premises, and DataRobot MLOps, which facilitates the deployment, monitoring, and management of machine learning models across organizations. The company also provides DataRobot Enterprise, featuring flexible deployment options, governance, and training services, along with packages designed to accelerate artificial intelligence projects. DataRobot serves a diverse range of industries, including banking, healthcare, manufacturing, and marketing, catering to business analysts, data scientists, and IT professionals. Founded in 2012 and headquartered in Boston, Massachusetts, DataRobot has expanded its operations globally, with offices in major cities such as London, Paris, and Tokyo, and maintains strategic partnerships to enhance its offerings.
Complexa
Series C in 2017
Complexa, Inc. is a biopharmaceutical company based in Berwyn, Pennsylvania, focused on developing treatments for severe and life-threatening diseases related to fibrosis and inflammation. Established in 2008, the company is advancing its lead compound, CXA-10, an oral nitrated fatty acid aimed at treating focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH). Complexa utilizes proprietary technologies that involve the synthesis of endogenous nitro-fatty acids, which serve as cell-signaling agents regulating key inflammatory pathways. This approach aims to enhance the body's natural mechanisms for resolving and repairing acute and chronic tissue injuries, with a focus on addressing various inflammatory, fibrotic, and central nervous system diseases.
Trevi Therapeutics
Series C in 2017
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, dedicated to developing and commercializing nalbuphine ER, an oral extended-release formulation. The company is focused on treating serious neurologically mediated conditions, specifically chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in individuals with Parkinson's disease. Trevi is currently conducting a Phase 2b/3 clinical trial, known as the PRISM trial, for nalbuphine ER, targeting severe pruritus associated with prurigo nodularis. The conditions being addressed share similar underlying mechanisms that involve opioid receptors in both the central and peripheral nervous systems. Founded in 2011, Trevi Therapeutics aims to provide innovative treatment options for patients suffering from these challenging health issues.
Catalog
Seed Round in 2017
Catalog is a developer of a data conversion and storage platform used to offer the next generation of digital data archives and computation. Its platform facilitates the encoding of data and information into DNA format and makes it economically attractive to use DNA as the major medium for long-term archival of data that enables customers to store digital information in DNA molecules. It brings cutting-edge synthetic biology technologies to the world of information storage and computation. The company was founded in 2016 and is headquartered in Boston, Massachusetts.
Transfix
Series C in 2017
Transfix, Inc. is a trucking brokerage firm based in New York that specializes in connecting shippers with carriers for freight transportation across the United States. Founded in 2010, the company has developed an online freight management platform that utilizes advanced algorithms and business intelligence to enhance supply chain visibility and efficiency. Transfix offers services such as real-time shipment tracking, carrier performance insights, and support tailored to various industries, including retail, food, beverage, and manufacturing. By leveraging its Intelligent Freight Platform, Transfix aims to optimize logistics processes, reduce empty miles, and improve overall supply chain performance for its clients.
Nuvolo
Series A in 2017
Nuvolo is an EAM platform that delivers a simple, intuitive, and user-friendly online and offline mobile experience. It is revolutionizing enterprise asset management by innovating on ServiceNow, an enterprise cloud platform. The company’s vision is to be the global leader in cloud-based EAM, powered by a culture of innovation and a relentless commitment to customer service. Fully optimized for growing, mobile workforces worldwide, Nuvolo delivers a simple, intuitive, and user-friendly online and offline mobile experience. It was founded in 2013 and is headquartered in Paramus, New Jersey with offices throughout the U.S. and internationally in London and Pune, India.
Casper
Series C in 2017
Casper is a sleep startup that launches a comfortable mattress sold directly to consumers, eliminating commission driven, inflated prices. Casper's mattresses are developed in-house by a team of product engineers with experience from IDEO. The company developed a line of core sleep products, including the Casper pillow, sheets, foundation, bed frame, duvet, and a dog mattress. The startup was founded in 2014 and is based in New York, United States.
Conviva
Venture Round in 2017
Conviva, Inc. is a technology company that specializes in optimizing over-the-top video experiences for broadcasters, operators, and content owners. Its intelligent control platform enables media companies to enhance audience engagement and improve brand loyalty by providing real-time insights into video quality and performance. Conviva's offerings include Conviva Insights, which aggregates quality metrics for online video businesses, and Conviva Precision, a tool that creates a multi-dimensional performance map for delivering a broadcast-like viewing experience. The platform processes nearly 3 trillion streaming data events daily, supporting over 500 million unique viewers across various applications. Conviva serves a diverse range of clients, including major brands in entertainment and sports, and operates globally from its headquarters in Silicon Valley, with additional offices in New York, London, Madrid, Bengaluru, Beijing, and Singapore. Founded in 2006 by professors from Carnegie Mellon and U.C. Berkeley, Conviva is backed by prominent investors and is dedicated to helping its clients maximize subscriber retention and understand viewing trends.
Tulip Interfaces
Series A in 2017
Tulip Interfaces, Inc. specializes in creating applications for the manufacturing industry that enhance shop floor operations. Founded in 2012 and based in Somerville, Massachusetts, the company offers a no-code platform that allows organizations to integrate data from various sources, including sensors and existing equipment. This integration facilitates the creation of digital work instructions and provides real-time visibility into operations, including the performance of personnel and machinery. Tulip serves a diverse range of industries, including consumer electronics, pharmaceuticals, apparel, and medical devices, helping companies improve productivity, quality, and operational efficiency. By leveraging advanced technologies such as intelligent hardware sensors, computer vision, and machine learning, Tulip's platform enables organizations to digitally transform their operations and achieve better end-to-end traceability.
Synlogic
Series C in 2017
Synlogic, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, specializing in the development of synthetic biotic medicines aimed at treating metabolic, inflammatory, and cancer-related diseases. The company’s lead therapeutic program, SYNB1618, is currently undergoing Phase I/IIa clinical trials for the treatment of phenylketonuria, a rare genetic metabolic disorder. Additionally, Synlogic is advancing SYNB1891, an intratumoral synthetic biotic medicine in Phase I clinical trials targeting solid tumors and lymphoma. The company employs a proprietary approach that utilizes engineered probiotics, specifically Escherichia coli Nissle 1917, to create GI-restricted oral therapies that are non-colonizing and reversible, facilitating easier administration and storage. Synlogic is also exploring treatments for other conditions, including secondary hyperoxaluria, inflammatory bowel disease, and various metabolic disorders, and has established a collaboration with Ginkgo Bioworks to further its development efforts.
Upskill
Series B in 2017
Upskill, Inc. specializes in designing and developing augmented reality software tailored for the industrial workforce. The company's flagship platform, Skylight, empowers businesses to create applications for smart glasses, facilitating enhanced communication and access to information for hands-on workers across various sectors, such as manufacturing, healthcare, logistics, and military. By connecting workers to essential processes, tools, and data, Skylight aims to improve operational efficiency, reduce errors, and streamline training for new employees. Upskill's innovative solutions enable organizations to increase productivity, enhance quality, and maintain competitiveness in a rapidly evolving market. Founded in 2010 and based in Vienna, Virginia, with additional offices in Cambridge and San Francisco, Upskill was formerly known as APX Labs before rebranding in 2017.
Maisonette
Seed Round in 2017
Maisonette Inc. is an online marketplace that specializes in baby and children's products, offering a curated selection of fashion, accessories, toys, furniture, and home decor for children aged 0-12. Established in 2016 and based in Brooklyn, New York, Maisonette aggregates a diverse range of quality items from a global network of brands and boutiques. This platform serves as a one-stop shopping destination for parents, providing them with a unified portal to access style-driven products at various price points, thereby simplifying the shopping experience for children's lifestyle needs.
Desktop Metal
Series C in 2017
Desktop Metal, Inc. specializes in additive manufacturing solutions, providing innovative 3D printing technologies tailored for engineers, designers, and manufacturers across various industries. Founded in 2015 and headquartered in Burlington, Massachusetts, the company offers a range of products, including the Production System for industrial manufacturing, the Shop System for metal additive manufacturing in machine and job shops, the Studio System for office-based metal 3D printing, and the Fiber desktop 3D printer. Its technologies cater to sectors such as automotive, aerospace, healthcare, consumer products, and heavy industry, enabling on-demand digital mass production that emphasizes speed, cost-efficiency, and high-quality parts. Desktop Metal operates in markets across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region, with the majority of its revenue generated from the Americas.
ClearMotion
Series C in 2017
ClearMotion, Inc. is an automotive technology company that specializes in developing advanced suspension systems to enhance vehicle comfort and handling. Founded out of MIT in 2008 and based in Billerica, Massachusetts, with operations in Nuneaton, United Kingdom, ClearMotion integrates hardware and software to create a proactive ride system that anticipates and counteracts shocks and vibrations from uneven road surfaces. This innovative technology not only improves ride quality but also enhances the overall user experience in vehicles. By mapping road surfaces in real-time, ClearMotion's system can mitigate the effects of road roughness almost instantaneously, ensuring a smoother ride for both drivers and passengers.
Intact Vascular
Series B in 2017
Intact Vascular, Inc. is a medical device company based in Wayne, Pennsylvania, focused on developing minimally invasive products for peripheral vascular procedures. Established in 2011, the company is known for its Tack Endovascular System, which enhances the results of peripheral balloon angioplasty in treating peripheral arterial disease (PAD) and critical limb ischemia (CLI). This innovative technology aims to improve clinical outcomes and quality of life for patients suffering from vascular diseases, offering physicians a new and effective treatment option. Intact Vascular is dedicated to creating safe, efficacious, and user-friendly medical devices for healthcare providers and their patients.
BuzzFeed
Series G in 2016
BuzzFeed, Inc. is a tech-driven media company that specializes in delivering breaking news, original reporting, and entertainment content across various digital platforms. Founded in 2006 and headquartered in New York, BuzzFeed engages a global audience with its diverse offerings, which include articles, quizzes, videos, and lifestyle content through well-known brands such as Tasty. The company also emphasizes investigative journalism through BuzzFeed News and produces original content for multiple formats via BuzzFeed Studios. Additionally, BuzzFeed Commerce focuses on social commerce products, licensing, and strategic partnerships. With a reach of over 200 million users, BuzzFeed aims to create shareable content that resonates across the social web.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.